Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
19 Jan 2012 | Global | Technology Research
Advances in Pharmacovigilance Techniques--Technology Benchmarking and Stakeholder Analysis (Technical Insights)
A Drug Safety Toolkit Moving toward Improved Drug Safety Systems
Pharmacovigilance activities revolve around ensuring drug safety and preventing adverse drug reactions. While post marketing studies form the core of pharmacovigilance, inclusion of safety measures during clinical development and carrying out additional post marketing active surveillance is being utilized by a number of pharma companies. Risks ...
$4,950.00 -
22 Feb 2013 | Global | Market Research
Overview of the Global Systemic Lupus Erythematosus Pipeline and the Next Three Potential Product Launches
This issue of Vital Signs discusses the change in 2015 Mammogram Guidelines, NeoGenomics' acquistion of Clarient from GE, and Tute Genomics' acquisition of Knome.
$1,500.00 -
03 Sep 2013 | Global | Technology Research
Innovations in Allergy Treatment and Monitoring (Technical Insights)
Therapy and Monitoring Advances Help Achieve Long-term Relief from Allergy
The global human plasma-derived therapeutics market is expected to experience a surge in demand due to an increase in the awareness of diseases and therapeutic options. The plasma-derived therapeutics market is segmented into albumin, immunoglobulins, coagulation factors, and other haemotologicals. The segments are discussed with supporting informa...
$4,950.00 -
08 Oct 2013 | Global | Market Research
Global Next Generation Sequencing Informatics Market
Informatics Vendors Flock to Growth in Sequencing Adoption
More than 100 companies participate in the global next generation sequencing (NGS) informatics market. This research service evaluates the market from 2012 to 2018. The research covers key market drivers and restraints, analysis of the changing competitive landscape, revenue forecasts, and the important trends that affect market growth. Also includ...
$4,950.00 -
28 Oct 2013 | Global | Customer Research
Competing in the Global Contract Manufacturing Market
What Pharmaceutical and Biotechnology Companies Want and How to Compete for their Business
The overall objective of this study was to provide contract manufacturing organizations (CMOs) a sound basis for formulating an effective strategy to compete in the market, including areas of opportunities and threats. As far as the market dynamics and CMO selection are concerned, overall satisfaction and likelihood of contract renewal are in the 4...
$10,000.00 -
19 Dec 2013 | Global | Market Research
Trends, Opportunities, and Challenges for the Latin American Diabetes Therapeutics Market
Innovative Drugs to Launch in the Next 3 Years, Impacting the Insulin and Non-insulin Markets
Biomarkers are no longer mere tools used to measure the criteria of a biological process characteristic. They are being increasingly used in patient stratification and customised medical interventions. This research service presents an overview and analysis of the global biomarker market. It provides revenue forecasts for biomarker on technological...
$2,450.00 -
09 Jan 2014 | Global | Market Research
Merger and Acquisition (M&A) Trends in the Global Pharmaceutical and Biotechnology Industry
Increasing Volume and Decreasing Value
This study investigates the global stem cell market for the period 2013 to 2018. The geographic regions covered in the study are the North America, Europe and APAC, followed by a detailed Asia Pacific Region Analysis, which covers countries such as India, Australia, Thailand, Singapore, South Korea, Malaysia and Japan. The stem cell market is cover...
$4,950.00 -
16 Jan 2014 | Global | Market Research
Analysis of the Global Biosimilars Market
Impending Patent Expiries and Next-generation Biosimilars Pipeline Provide Impetus for Growth
Prescription drug therapy for the treatment of obesity is experiencing a revival of interest with new government incentives and the recent approval of 2 new drugs, with 2 more pending imminent approval. This research service focuses on the competitive landscape of prescription drugs for the treatment of obesity. A global product and pipeline asse...
$10,000.00 -
11 Jun 2014 | Global | Market Research
Analysis of the Western European Next Generation Sequencing (NGS) Market
Clinical Applications Grow, Regulations Stiffen, Acquisitions Mount
This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinica...
$4,950.00 -
20 Jun 2014 | Global | Market Research
Global Next-generation Sequencing Market
On the Verge of a Quadrupled Competitor Size and a Clinical Turning Point
The total market, as defined by this study, includes next-generation sequencing instruments and reagents. Instruments include those that use newer technology than traditional capillary electrophoresis (CE) sequencing, such as sequencing-by-synthesis, sequencing-by-ligation, single-molecule sequencing, and semiconductor sequencing. This research ser...
$10,000.00
